Stocks and Investing
Stocks and Investing
Thu, June 9, 2022
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
[ Thu, Jun 09th 2022
] - WOPRAI
Naz Rahman Initiated (VRPX) at Strong Buy and Held Target at $40 on, Jun 9th, 2022
Naz Rahman of Maxim Group, Initiated "Virpax Pharmaceuticals, Inc." (VRPX) at Strong Buy and Held Target at $40 on, Jun 9th, 2022.
Naz, nor any peers, have made any analyst calls on VRPX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources